MEA Patient Monitoring Market

MEA Patient Monitoring Market Size (2023 to 2028)

The Middle East and Africa Patient Monitoring market were estimated at USD 8.61 Billion in 2023. It is forecasted to grow and be worth USD 12.47 Billion by 2028, registering a CAGR of 7.69% from 2023 to 2028.

Patient Monitoring Systems enable efficient healthcare delivery to patients outside the conventional hospital or clinical settings, by transmitting real-time patient data for clinical review. This can reduce mortality rates and facilitate the efficient use of medical resources. These help in avoiding emergency overcrowding, managing a huge number of patients, and enhanced maintenance of electronic health records (EHR). 

The Middle East and Africa patient monitoring market is expected to grow rapidly at a tremendous rate during the forecast period. Key factors driving the growth of this market is the increasing burden of chronic diseases due to lifestyle changes, ease of use and device portability, the introduction of remote monitoring systems, more number of critically ill geriatric cases, an increase in the prevalence of diseases such as heart disorders and diabetes, etc., and an increase in demand for home and non-invasive surveillance systems. Patient monitoring reduces readmissions and lowers hospitalizations, reduces the number of unnecessary trips to the doctor's office, decreases travel costs, and is more patient-friendly. There is a growing demand for efficient home monitoring devices namely thermometers, pulse oximeters, pedometers, ECG monitors, respiratory analyzers, EEG recorders, and fetal monitors. In addition, the number of hospital readmissions has declined significantly due to patient monitoring devices.

A recent analysis showed that 15 percent of the Saudi Arabian population suffer from hypertension, which increases the risk factor for cardiovascular diseases. CVD is the primary cause of death worldwide and is more prevalent in low- and middle-income countries. This amounts to 31 percent of all deaths or nearly 19 million deaths annually in Saudi Arabia. Other factors such as the growing preference for remote and home monitoring, and advancements in technology are promoting the market growth. In recent years, increasing healthcare spending, especially in hospital settings, has shifted attention to alternative methods of treatment, such as remote patient monitoring. The patient monitoring system advocates self-care, healthcare motivation, and real-time data collection.

High investments in research and development activities for the development of advanced products and wireless technology adoption are also expected to drive the growth of the MEA patient monitoring market.

However, several factors such as competitive pricing, invasive monitoring systems, reimbursement policies, patient compliance, and difficulty in understanding older patients are expected to restraint the MEA patient monitoring market during the projected period. In addition, certain side effects with improper use can lead to bleeding, sepsis, nerve damage, necrosis, etc., these may have a negative impact on the market growth.

This research report on the Middle East and Africa Patient Monitoring Market has been segmented and sub-segmented into the following categories:

By Application:

• Neuromonitoring Devices

  • Electroencephalograph (EEG)

  • Transcranial Doppler (TCD)

  • Magnetoencephalography (MEG)

  • Cerebral Oximeters

  • Intracranial Pressure Monitors (ICP)

• Hemodynamic Monitoring Devices

  • Blood Pressure Monitors

  • Blood Glucose Monitors

  • Blood Gas and Electrolyte Analyzers

  • Cholesterol Analyzers

• Cardiac Monitoring Devices             

  • Electrocardiogram (ECG) 

  • Event Monitors

  • Implantable Loop Recorder (ILR) 

  • Cardiac Output Monitoring Devices 

• Fetal and neonatal Monitoring Devices      

  • Ultrasound Fetal Dopplers 

  • Internal Fetal Monitors

• Respiratory Monitoring Devices     

  • Capnography 

  • Spirometers 

  • Anesthesia Monitors 

  • Sleep Apnea Monitoring Devices 

  • Pulse Oximeters

• Multi-Parameter Monitoring Devices          

  • High-Acuity Monitors 

  • Mid-Acuity Monitors 

  • Low-Acuity Monitors

• Temperature Monitoring Devices 

• Weight Monitoring Devices             

• Remote Patient Monitoring Devices

By Country: 

• KSA

• UAE

• Israel

• rest of GCC countries

• South Africa

• Ethiopia

• Kenya

• Egypt

• Sudan

• rest of MEA

The Middle East & Africa patient monitoring market is expected to grow due to the increasing prevalence of cardiovascular diseases and other chronic diseases. The United Arab Emirates is projected to dominate the MEA patient monitoring market during the analysis period. The integration of monitoring technologies into smartphones and wireless devices is a key trend in patient care, leading to, and evolution for newer and better products with quick and reliable data. UAE captured the largest share of the MEA patient monitoring market in 2019 and is studied to continue with the trend.

The regional market in Saudi Arabia and South Africa has grown in popularity in the remote management of patients for the treatment of chronic diseases. Telemedicine has grown rapidly with the Middle East & Africa patient monitoring market. Digitalization and healthcare are helping patients with better diagnostics and treatment options. Rural areas in the MEA region have greatly benefitted from teleconsultation and periodic vital stats records. Increasing R&D to develop real-time patient monitoring systems, growing focus on healthcare with more expenditures, and encouraging patient education are factors driving the MEA patient monitoring market.

However, there are some regions in MEA, which will hold back growth in the future due to high initial capital, poor implementation, lack of awareness, inadequate reimbursement policies, and lack of skilled workers in these areas.

Prominent companies operating in the MEA Patient Monitoring Market are Abbott Laboratories, Masimo Corporation, Covidien, Drager Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn.